3.82
price up icon2.14%   0.08
after-market 시간 외 거래: 3.82
loading
전일 마감가:
$3.74
열려 있는:
$3.7708
하루 거래량:
412.50K
Relative Volume:
0.41
시가총액:
$223.82M
수익:
-
순이익/손실:
$-117.81M
주가수익비율:
-2.0319
EPS:
-1.88
순현금흐름:
$74.30M
1주 성능:
+8.83%
1개월 성능:
+19.75%
6개월 성능:
-57.60%
1년 성능:
-30.16%
1일 변동 폭
Value
$3.74
$3.855
1주일 범위
Value
$3.34
$3.855
52주 변동 폭
Value
$2.95
$13.60

Omeros Corporation Stock (OMER) Company Profile

Name
명칭
Omeros Corporation
Name
전화
206-676-5000
Name
주소
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Name
직원
202
Name
트위터
@OmerosCorp
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
OMER's Discussions on Twitter

OMER을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
OMER
Omeros Corporation
3.82 219.14M 0 -117.81M 74.30M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Omeros Corporation Stock (OMER) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-10 개시 H.C. Wainwright Buy
2024-12-23 개시 D. Boral Capital Buy
2024-11-14 개시 Rodman & Renshaw Buy
2022-12-08 다운그레이드 UBS Buy → Neutral
2022-11-08 다운그레이드 BofA Securities Neutral → Underperform
2022-06-08 다운그레이드 BofA Securities Buy → Neutral
2021-10-08 다운그레이드 JP Morgan Neutral → Underweight
2021-10-01 다운그레이드 Maxim Group Buy → Hold
2021-10-01 다운그레이드 Wedbush Neutral → Underperform
2021-09-27 개시 JP Morgan Neutral
2021-02-01 개시 UBS Buy
2020-10-20 개시 BofA Securities Buy
2020-08-21 재확인 H.C. Wainwright Buy
2020-08-14 재확인 Maxim Group Buy
2019-05-06 개시 Cantor Fitzgerald Overweight
2018-07-12 개시 Seaport Global Securities Buy
2018-03-23 다운그레이드 Wedbush Outperform → Neutral
2018-03-05 다운그레이드 Needham Buy → Hold
2017-11-08 개시 H.C. Wainwright Buy
2017-05-11 다운그레이드 Cantor Fitzgerald Buy → Neutral
2017-03-17 재확인 Maxim Group Buy
2017-03-17 재확인 Needham Buy
2016-11-16 재확인 Wedbush Outperform
2016-11-10 재확인 Needham Buy
2016-08-10 재확인 Maxim Group Buy
2016-06-03 개시 Cantor Fitzgerald Buy
2016-03-02 재확인 Needham Buy
2016-02-29 재확인 Wedbush Outperform
2015-11-11 재확인 Needham Buy
2015-08-18 재확인 WBB Securities Strong Buy
2015-08-10 개시 ROTH Capital Buy
모두보기

Omeros Corporation 주식(OMER)의 최신 뉴스

pulisher
07:24 AM

Omeros Corporation Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com

07:24 AM
pulisher
06:18 AM

What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com

06:18 AM
pulisher
Jul 22, 2025

What analysts say about Omeros Corporation stockDynamic capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Is Omeros Corporation a good long term investmentSky-high profits - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

How Omeros Corporation stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

what makes omeros corporation stock price move sharplyFree Access to Community - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

FY2027 Earnings Forecast for Omeros Issued By HC Wainwright - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Omeros Corporation stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 11, 2025
pulisher
Jul 07, 2025

Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

Wealth Enhancement Advisory Services LLC Takes $579,000 Position in Omeros Corporation (NASDAQ:OMER) - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Both retail investors who control a good portion of Omeros Corporation (NASDAQ:OMER) along with institutions must be dismayed after last week's 12% decrease - simplywall.st

Jul 03, 2025
pulisher
Jul 02, 2025

Omeros shareholders elect directors and approve executive pay at annual meeting - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

Omeros stock maintains Buy rating at H.C. Wainwright on EU submission - Investing.com

Jun 30, 2025
pulisher
Jun 28, 2025

Omeros (NASDAQ:OMER) Downgraded by Wall Street Zen to “Sell” - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

Omeros' Narsoplimab: A Lifeline for TA-TMA Patients and a Regulatory Crossroads - AInvest

Jun 27, 2025
pulisher
Jun 27, 2025

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA | OMER Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Omeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 24, 2025

Omeros Announces Webcast Details for Annual Meeting of Shareholders - The Joplin Globe

Jun 24, 2025
pulisher
Jun 16, 2025

Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program - mx.advfn.com

Jun 09, 2025
pulisher
Jun 08, 2025

Omeros (NASDAQ:OMER) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 08, 2025

Omeros Corporation (OMER) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):